Antibody to Certolizumab Pegol ELISA
Enzyme immunoassay for the quantitative and qualitative determination of free antibodies to Certolizumab Pegol (Cimzia®) in serum and plasma.
The solid phase (MTP) is coated by the drug Certolizumab Pegol. Due to the assay design this test only measures the free antibodies which are not bound to Certolizumab Pegol. Results are expressed in AU (arbitrary units).
Reference: IG-BB109
Barcode: 8682754930264
Legal Status: CE Mark
Intended Use: This kit has been developed for the detection of anti-drug antibodies in research and diagnostic uses. It is suitable for Therapeutical Drug Monitoring (TDM) purposes.
Assay Design:
Related Documents
Instructions for Use IG-BB109 906.36 KB
Material Safety Data Sheet (MSDS) IG-BB109 270.42 KB
Cimzia® is a trademark of UCB.
The Kit at a glance:
| Required Volume (µL) | 50 |
| Incubation Time (min) | 165 |
| Sample | Serum/Plasma |
| Package Size | 96 Tests |
| Results in | Qualitative&Quantitative(ng/mL) |
| Shelf Life (years) | 2 |